Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publications

  • Irving, JA; Catasus, L; Gallardo, A; Bussaglia, E; Romero, M; Matias-Guiu, X; Prat, J

    Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis

    HUMAN PATHOLOGY 36 605-619. .

    [doi:10.1016/j.humpath.2005.03.005]

  • Dolcet, X; Llobet, D; Pallares, J; Matias-Guiu, X

    NF-kB in development and progression of human cancer.

    VIRCHOWS ARCHIV 446 475-482. .

    [doi:10.1007/s00428-005-1264-9]

  • Pallares, J; Bussaglia, E; Martinez-Guitarte, JL; Dolcet, X; Llobet, D; Rue, M; Sanchez-Verde, L; Palacios, J; Prat, J; Matias-Guiu, X

    Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities.

    Modern Pathology 18 719-727. .

    [doi:10.1038/modpathol.3800347]

  • Isidro, ML; Diaz, PI; Matias-Guiu, X; Cordido, F

    Acromegaly due to a growth hormone-releasing hormone-secreting intracranial gangliocytoma

    Journal Of Endocrinological Investigation 28 162-165. .

  • Pallares, J; Martinez-Guitarte, JL; Dolcet, X; Llobet, D; Rue, M; Palacios, J; Prat, J; Matias-Guiu, X

    Abnormalities in the NF-kappaB family and related proteins in endometrial carcinoma.

    JOURNAL OF PATHOLOGY 204 569-577. .

    [doi:10.1002/path.1666]

  • Vidal, D; Matias-Guiu, X; Alomar, A

    Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma

    CLINICAL AND EXPERIMENTAL DERMATOLOGY 29 518-525. .

    [doi:10.1111/j.1365-2230.2004.01601.x]

  • Vidal, D; Matias-Guiu, X; Alomar, A

    Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis

    BRITISH JOURNAL OF DERMATOLOGY 151 656-662. .

    [doi:10.1111/j.1365-2133.2004.06094.x]

  • Toll, A; Gilaberte, M; Matias-Guiu, X; Camacho, L; Alomar, A; Gonzalez-Gay, MA; Pujol, RM

    Kikuchi's disease (necrotizing lymphadenitis) with cutaneous involvement associated with subacute cutaneous lupus erythematosus

    CLINICAL AND EXPERIMENTAL DERMATOLOGY 29 240-243. .

    [doi:10.1111/j.1365-2230.2004.01454.x]

  • Moreno-Bueno, G; Hardisson, D; Prat, J; Matias-Guiu, J; Palacios, J

    Re: Scholten et al. nuclear beta-catenin is a molecular feature of type I endometrial carcinoma. J Pathol 2003; 201 : 460-465

    JOURNAL OF PATHOLOGY 202 511-512. .

    [doi:10.1002/path.1540]

  • Trovisco, V; de Castro, IV; Soares, P; Maximo, V; Silva, P; Magalhaes, J; Abrosimov, A; Guiu, XM; Sobrinho-Simoes, M

    BRaF mutations are associated with some histological types of papillary thyroid carcinoma

    JOURNAL OF PATHOLOGY 202 247-251. .

    [doi:10.1002/path.1511]

  • Valenzuela, N; Barnadas, MA; Matias-Guiu, X; Curell, R; de Andres, L; Alomar, A

    Lethal perianal Buschke-Lowenstein tumor in a female patient with aIDS

    Dermatology 208 349-350. .

    [doi:10.1159/000077847]

  • Pallares, J; Perez-Ruiz, L; Ros, S; Panades, J; Pardo-Mindan, J; Lloreta, J; Matias-Guiu, X

    Malignant peripheral nerve sheath tumor of the thyroid: a clinicopathological and ultrastructural study of one case.

    ENDOCRINE PATHOLOGY 15 167-174. .

    [doi:10.1385/EP:15:2:167]

Projects

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU